Literature DB >> 33129877

HIF/Ca2+/NO/ROS is critical in roxadustat treating bone fracture by stimulating the proliferation and migration of BMSCs.

Chunxia Chen1, Shihai Yan2, Shuang Qiu1, Zhirong Geng3, Zhilin Wang4.   

Abstract

AIMS: Fracture site is regionally hypoxic resulting from vasculature disruption. HIF-1αplays an essential role in fracture repair. This study aims to investigate the influence of FG4592 on the femur fracture of SD rats and the proliferation, migration of BMSCs.
MATERIALS AND METHODS: After the femoral fracture model was established, computed tomography imaging and histological analyses were used to quantify bone healing and the expression of CD90, HIF-1α, VEGF were observed by means of immunohistochemistry method on Day 10 and Day 20. In addition, CCK-8 assay, transwell, flow cytometric analysis, laser confocal microscopy assay, western blot and rT-PCR were performed to text the proliferation and migration of BMSCs using FG4592. KEY
FINDINGS: In vivo, FG4592 facilitated the repair of bone fracture by increasing the number of BMSCs and cartilage formation. In vitro, FG4592 markedly improved the proliferation, migration of BMSCs via upregulation of intracellular Ca2+, NO and concomitant decrease of ROS. Gene silencing of HIF-1α resulted in the opposite phenomenon in BMSCs with the treatment of FG4592. SIGNIFICANCE: The transplantation of BMSCs is the most promising candidate for the treatment of fracture non-union. We illustrated that FG4592 promoted the proliferation, migration of BMSCs via the HIF/Ca2+/NO/ROS pathway and further accelerated fracture healing. These results provide a deeper understanding for the mechanism of HIF in promoting fracture healing.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BMSCs; Ca(2+)/NO/ROS; FG4592; Fracture; HIF-1α; Proliferation, migration

Mesh:

Substances:

Year:  2020        PMID: 33129877     DOI: 10.1016/j.lfs.2020.118684

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

1.  Roxadustat promotes osteoblast differentiation and prevents estrogen deficiency-induced bone loss by stabilizing HIF-1α and activating the Wnt/β-catenin signaling pathway.

Authors:  Luyao Li; Afang Li; Li Zhu; Liangying Gan; Li Zuo
Journal:  J Orthop Surg Res       Date:  2022-05-21       Impact factor: 2.677

Review 2.  Impact of High-Altitude Hypoxia on Bone Defect Repair: A Review of Molecular Mechanisms and Therapeutic Implications.

Authors:  Pei Chen; Yushan Liu; Wenjing Liu; Yarong Wang; Ziyi Liu; Mingdeng Rong
Journal:  Front Med (Lausanne)       Date:  2022-05-10

3.  Comprehensive analysis of lncRNA-miRNA-mRNA networks during osteogenic differentiation of bone marrow mesenchymal stem cells.

Authors:  Jialin Liu; Yuan Yao; Jinyong Huang; Hao Sun; Yixuan Pu; Mengting Tian; Meijie Zheng; Huiyu He; Zheng Li
Journal:  BMC Genomics       Date:  2022-06-07       Impact factor: 4.547

4.  Enhancing fracture repair: cell-based approaches.

Authors:  John Wixted; Sravya Challa; Ara Nazarian
Journal:  OTA Int       Date:  2022-03-10

Review 5.  Roxadustat: Not just for anemia.

Authors:  Xiaoyu Zhu; Lili Jiang; Xuejiao Wei; Mengtuan Long; Yujun Du
Journal:  Front Pharmacol       Date:  2022-08-29       Impact factor: 5.988

6.  Low level laser therapy promotes bone regeneration by coupling angiogenesis and osteogenesis.

Authors:  Jie Bai; Lijun Li; Ni Kou; Yuwen Bai; Yaoyang Zhang; Yun Lu; Lu Gao; Fu Wang
Journal:  Stem Cell Res Ther       Date:  2021-08-03       Impact factor: 6.832

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.